MCID: MCC002
MIFTS: 50

Mucocutaneous Leishmaniasis malady

Category: Infectious diseases

Aliases & Classifications for Mucocutaneous Leishmaniasis

About this section

Aliases & Descriptions for Mucocutaneous Leishmaniasis:

Name: Mucocutaneous Leishmaniasis 10 12 65
American Cutaneous Leishmaniasis 10 65
Mucocutaneous Leishmaniasis, American 10
American Mucocutaneous Leishmaniasis 10
 
Cutaneous Leishmaniasis, American 10
New World Cutaneous Leishmaniasis 10
Mucocutaneous Leishmaniasis, 10
Leishmaniasis, Mucocutaneous 36

Classifications:



External Ids:

Disease Ontology10 DOID:9155
ICD1027 B55.2
ICD9CM29 085.5
MeSH36 D007897
UMLS65 C1328252, C3495436

Summaries for Mucocutaneous Leishmaniasis

About this section
Disease Ontology:10 A leishmaniasis that involves a chronic inflammatory process involving the nasal, pharyngeal, and laryngeal mucosa, which can lead to extensive tissue destruction, caused by protozoan parasites belonging to the genus Leishmania. The infection is characterized by granulomatous lesion which can destroy upper respiratory tract mucosa.

MalaCards based summary: Mucocutaneous Leishmaniasis, also known as american cutaneous leishmaniasis, is related to leishmaniasis and pituitary apoplexy. An important gene associated with Mucocutaneous Leishmaniasis is CD4 (CD4 Molecule), and among its related pathways are Primary immunodeficiency and IL-10 Pathway. Affiliated tissues include prostate, breast and spinal cord, and related mouse phenotypes are integument and endocrine/exocrine gland.

Related Diseases for Mucocutaneous Leishmaniasis

About this section

Diseases related to Mucocutaneous Leishmaniasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 209)
idRelated DiseaseScoreTop Affiliating Genes
1leishmaniasis11.3
2pituitary apoplexy10.6CD4, CD8A
3hyperhomocysteinemia10.6CD4, CD8A
4malignant cornea melanoma10.6CD4, CD8A
5acute cystitis10.6CD4, CD8A
6cd3epsilon deficiency10.6CD4, CD8A
7mycotic corneal ulcer10.6CD4, CD8A
8monkeypox10.6CD4, CD8A
9neurotic disorder10.6CD4, IL10
10rem sleep behavior disorder10.6CD4, CD8A
11toxic maculopathy10.6CD4, CD8A
12coronin-1a deficiency10.6CD4, CD8A
13leukocyte disease10.6CD4, CD8A
14desquamative interstitial pneumonia10.6CD4, CD8A
15microsporidiosis10.6CD4, CD8A
16late congenital syphilis10.6CD4, CD8A
17lichen disease10.6CD4, CD8A
18pityriasis rosea10.6CD4, CD8A
19enophthalmos10.6CD4, CD8A
20inflammatory leiomyosarcoma10.6CD4, CD8A
21myositis ossificans10.6CD4, CD8A
22juvenile spinal muscular atrophy10.6CD4, CD8A
23hyperinsulinism10.6CD4, CD8A
24rhabdoid cancer10.6CD4, CD8A
25paralytic squint10.6CD4, CD8A
26pharyngoconjunctival fever10.6CD4, CD8A
27vein disease10.6CD4, CD8A
28arcus senilis10.6CD4, CD8A
29rheumatic myocarditis10.6CD4, IL4
30autoimmune disease of cardiovascular system10.6CD4, CD8A
31status asthmaticus10.6CD4, IL4
32cervical incompetence10.5CD4, CD8A
33cycloplegia10.5IL10, IL4
34eosinophilic gastroenteritis10.5CD4, IL4
35internal hordeolum10.5CD4, CD8A
36extrapulmonary tuberculosis10.5CD4, IL4
37mobitz type ii atrioventricular block10.5CD4, IL4
38interleukin-7 receptor alpha deficiency10.5CD4, CD8A
39dioctophymiasis10.5IL10, IL4
40female breast central part cancer10.5CD4, CD8A
41penicillin allergy10.5IL10, IL4
42superficial urinary bladder cancer10.5IL10, IL4
43neurofibromatosis10.5CD4, IL4
44buruli ulcer10.5IL10, IL4
45nemaline myopathy10.5CD4, CD8A
46clivus chordoma10.5CD4, CD8A
47parathyroid gland disease10.5CD4, CD8A
48ethmoid sinus squamous cell carcinoma10.5CD4, TNF
49cow milk allergy10.5IL10, IL4
50relapsing polychondritis10.5CD4, CD8A

Graphical network of the top 20 diseases related to Mucocutaneous Leishmaniasis:



Diseases related to mucocutaneous leishmaniasis

Symptoms for Mucocutaneous Leishmaniasis

About this section

Drugs & Therapeutics for Mucocutaneous Leishmaniasis

About this section

Drugs for Mucocutaneous Leishmaniasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 21)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Anti-Infective AgentsPhase 2, Phase 3, Phase 117220
2Antiprotozoal AgentsPhase 2, Phase 3, Phase 11730
3meglumine antimoniatePhase 2, Phase 325
4Antiparasitic AgentsPhase 2, Phase 3, Phase 11854
5
Miconazoleapproved, investigationalPhase 2, Phase 1302622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
6
Amphotericin Bapproved, investigationalPhase 2, Phase 11171397-89-314956, 5280965
Synonyms:
12633-72-6
1397-89-3
30782-62-8
5-18-10-00525 (Beilstein Handbook Reference)
54482-28-9
8055-20-7
AB00513832
ABLC
AC1L1CN2
AC1L24V6
AC1L70KF
AC1L73U6
AC1NQXTD
AC1NTQ32
AC1NUQG4
AC1NY9JC
AC1O7GCZ
AC1O8FQV
AC1O8PFK
AI3-26528
AMPH-B
AMPH-b
Abelcet
Abelecet
AmBisome (TN)
Ambap1397-89-3
Ambisome
Amfotericina B
Amfotericina B [INN-Spanish]
Ampho-Moronal
Amphocin
Amphomoronal
Amphortericin B
Amphotec
Amphotec (TN)
Amphotericin
Amphotericin .BETA.
Amphotericin B
Amphotericin B (JP15/USP/INN)
Amphotericin B Cholesterol Dispersion
Amphotericin B Cholesteryl Sulfate Complex
Amphotericin B Colloidal Dispersion
Amphotericin B [USAN:INN:JAN]
Amphotericin B, Lipid-based
Amphotericin B, Streptomyces sp.
Amphotericin-B
Amphotericine B
Amphotericine B [INN-French]
Amphotericinum
Amphotericinum B
Amphotericinum B [INN-Latin]
Amphotherizin
Amphotherizin [German]
Amphotéricine B
Amphozone
BIDD:GT0351
BPBio1_000374
BRN 0078342
BSPBio_000340
C-AmB
C06573
C47H73NO17
CCRIS 5963
CHEBI:2682
CHEMBL1200646
CHEMBL267345
CID10533925
CID10629638
CID10677275
CID14956
 
CID1972
CID352546
CID354192
CID5280965
CID5386092
CID5458486
CID5771695
CID6604295
CID6708817
CID6713692
CID9919339
D00203
DB00681
DivK1c_007045
EINECS 215-742-2
Fungilin
Fungisome
Fungisone
Fungizone
Fungizone (TN)
HMS1569A22
HSDB 3008
HSDB 3008 IAB
Halizon
I06-0257
KBio1_001989
KBio2_000551
KBio2_003119
KBio2_005687
KBioGR_002298
KBioSS_000551
LMPK06000002
LNS-AmB
LS-187721
LS-93
Liposomal Amphotericin B
Liposomal amphotericin b
MLS002702966
MolPort-006-392-260
Mysteclin-F
NCGC00014913
NCGC00090808-01
NCGC00098014-01
NCGC00179595-01
NCI527017
NCI60_004288
NCIStruc1_001042
NCIStruc2_000920
NKTR-024
NS 718
NSC 527017
NSC-527017
NSC527017
Prestwick0_000410
Prestwick1_000410
Prestwick2_000410
Prestwick3_000410
Prestwick_721
SMP1_000302
SMR001566780
SPBio_000715
SPBio_002279
ST50999656
SinuNase
SpecPlus_000949
Spectrum2_000818
Spectrum4_001779
Spectrum_000111
UNII-7XU7A7DROE
amophotericin B
amphotericin B liposomal
amphotericin b
7
MiltefosineapprovedPhase 2, Phase 13358066-85-63600
Synonyms:
1-Hexadecylphosphorylcholine
2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide, inner salt
3,5-Dioxa-4-phosphaunacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide
4-04-00-01460 (Beilstein Handbook Reference)
58066-85-6
AC1L1GAH
BRN 3690495
Baxter Oncology brand of miltefosine
Baxter brand of miltefosine
C039128
C15H32.C7H17NO4P
CHEBI:125047
CHEMBL125
CID3599
Choline hydroxide, hexadecyl hydrogen phosphate, inner salt
Choline phosphate, hexadecyl ester, hydroxide, inner salt
Choline phosphate, hexadecyl ester, hydroxide, inner salt (6CI)
Choline, hexadecyl hydrogen phosphate, inner salt
D 18506
D-18506
D02494
D18506
Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, inner salt
Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, innner salt
H-1850
HDPC
HMS1922D16
HMS2089J15
HePC
Hexadecyl 2-(trimethyl-.lambda.~5~-azanyl)ethyl hydrogen phosphate
 
Hexadecylphosphocholine
Hexadecylphosphorylcholine
I14-7244
IN1227
Impavido
LS-65132
M-7200
Miltefosin
Miltefosin C
Miltefosina
Miltefosina [INN-Spanish]
Miltefosine
Miltefosine (INN)
Miltefosine [INN:BAN]
Miltefosinum
Miltefosinum [INN-Latin]
Miltex
Miltéfosine
MolPort-003-665-519
Monohexadecylphosphocholine
Monohexadecylphosphorylcholine
NCGC00095169-01
NCGC00095169-02
NCGC00095169-03
NSC605583
Prasfarma brand of miltefosine
SPECTRUM1505329
ST51055612
TF-002
UNII-53EY29W7EC
hexadecyl 2-(trimethylazaniumyl)ethyl phosphate
n-Hexadecylphosphorylcholine
8
Pentoxifyllineapproved, investigationalPhase 2906493-05-64740
Synonyms:
1,2,3,6-Tetrahydro-3,7-dimethyl-1-(5-oxohexyl)-2,6-purindion
1-(5-Oxohexyl)-3,7-dimethylxanthine
1-(5-Oxohexyl)theobromine
2a3c
3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxo-hexyl)-3,7-dihydro-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl) xantine
3,7-Dimethyl-1-(5-oxohexyl)-1H,3H-purin-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)xanthine
3,7-Dimethyl-1-(5-oxohexyl)xantine
3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
5-26-14-00081 (Beilstein Handbook Reference)
6493-05-6
AB00052363
AC1L1IUN
AKOS000541484
Agapurin
Agapurin Retard
Azupentat
BAS 00897429
BB_SC-2111
BIDD:GT0174
BL 191
BL-191
BL191
BPBio1_000167
BRD-K57569181-001-05-1
BRN 0558929
BSPBio_000151
BSPBio_003439
C07424
C13H18N4O3
CAS-1677687
CCRIS 6832
CHEMBL628
CID4740
CPD000035998
D00501
D010431
DB00806
Dimethyloxohexylxanthine
DivK1c_000729
Durapental
EHT 0201
EHT-0201
EHT-201
EHT0201
EINECS 229-374-5
EU-0100936
HMS1568H13
HMS1922E16
HMS2051N06
HMS2090H13
HMS2093G21
HMS502E11
Hemovas
I06-1592
IDI1_000729
IN1161
Ikomio
KBio1_000729
KBio2_001924
KBio2_004492
KBio2_007060
KBio3_002942
KBioGR_000893
KBioSS_001924
LS-149385
 
Lopac-P-1784
Lopac0_000936
MLS000079026
MLS000758298
MLS001201764
MolPort-001-823-263
NCGC00015801-01
NCGC00015801-02
NCGC00015801-04
NCGC00015801-10
NCGC00067069-02
NCGC00067069-03
NCGC00067069-04
NCGC00067069-05
NCGC00178062-01
NCGC00178062-02
NINDS_000729
NSC 637086
NSC637086
Oxpentifylline
P 1784
PDSP1_001015
PDSP2_000999
PENTOXYPHYLINE
PNX
Pentoxifilina
Pentoxifilina [INN-Spanish]
Pentoxifyllin
Pentoxifylline
Pentoxifylline (JAN/USP/INN)
Pentoxifylline [USAN:INN:JAN]
Pentoxifyllinum
Pentoxifyllinum [INN-Latin]
Pentoxil
Pentoxil (TN)
Pentoxiphyllin
Pentoxiphylline
Pentoxiphyllium
Pentoxyfylline
Pentoxyphyllin
Pentoxyphylline
Prestwick0_000196
Prestwick1_000196
Prestwick2_000196
Prestwick3_000196
Prestwick_608
Px
Ralofect
Rentylin
SAM001247011
SMR000035998
SPBio_001221
SPBio_002072
SPECTRUM1503611
SR-01000075641-4
STK177321
Spectrum2_001181
Spectrum3_001820
Spectrum4_000227
Spectrum5_001161
Spectrum_001444
Torental
Trental
Trental (TN)
UNII-SD6QCT3TSU
Vasofirin
Vazofirin
ZINC01530776
cis-9-Octadecenoyl coenzyme A
pentoxifylline
9Liposomal amphotericin BPhase 2, Phase 1117
10Antimony Sodium GluconatePhase 2, Phase 115
11Antifungal AgentsPhase 2, Phase 13015
12AnthelminticsPhase 2, Phase 1379
13Coal TarPhase 2165
14Radiation-Protective AgentsPhase 2333
15Vasodilator AgentsPhase 22926
16Protective AgentsPhase 25651
17Platelet Aggregation InhibitorsPhase 21935
18Phosphodiesterase InhibitorsPhase 21062
19AntioxidantsPhase 22442
20VaccinesPhase 16085
21Immunologic FactorsPhase 118483

Interventional clinical trials:

(show all 14)
idNameStatusNCT IDPhase
1Low Antimonial Dosage in American Mucosal LeishmaniasisRecruitingNCT01301937Phase 2, Phase 3
2Clinical Trial of Miltefosine to Treat Mucosal LeishmaniasisCompletedNCT01377974Phase 2
3Miltefosine to Treat Mucocutaneous LeishmaniasisCompletedNCT01050907Phase 2
4Miltefosine for Mucosal LeishmaniasisCompletedNCT00373776Phase 1, Phase 2
5Miltefosine (Long Course) for Bolivian Mucosal LeishmaniasisCompletedNCT00373568Phase 1, Phase 2
6Sodium Stibogluconate Treatment of LeishmaniasisCompletedNCT00662012Phase 2
7Miltefosine to Treat Cutaneous Leishmaniasis in BoliviaCompletedNCT00233545Phase 2
8The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in BrazilRecruitingNCT02530697Phase 2
9Use of Sodium Stibogluconate as a Treatment for LeishmaniasisEnrolling by invitationNCT00657618Phase 1, Phase 2
10Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal LeishmaniasisCompletedNCT00111514Phase 1
11Diagnosis and Treatment of Leishmanial InfectionsRecruitingNCT00344188
12Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World LeishmaniasisAvailableNCT00508963
13Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous LeishmaniasisNot yet recruitingNCT02429518
14Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous LeishmaniasisNot yet recruitingNCT02431429

Search NIH Clinical Center for Mucocutaneous Leishmaniasis


Cochrane evidence based reviews: leishmaniasis, mucocutaneous

Genetic Tests for Mucocutaneous Leishmaniasis

About this section

Anatomical Context for Mucocutaneous Leishmaniasis

About this section

MalaCards organs/tissues related to Mucocutaneous Leishmaniasis:

33
Prostate, Breast, Spinal cord, Liver, Heart, T cells, Endothelial

Animal Models for Mucocutaneous Leishmaniasis or affiliated genes

About this section

MGI Mouse Phenotypes related to Mucocutaneous Leishmaniasis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107718.7CD4, CD8A, IL10, IL4, TNF
2MP:00053797.9CD4, CD8A, IL10, IL4, LTA, TNF
3MP:00053917.4IL10, IL4, LTA, NID1, SCYL1, TNF
4MP:00107686.9CD4, CD8A, IL10, IL4, LTA, SCYL1
5MP:00053976.9CD4, CD8A, IL10, IL4, LTA, SCYL1
6MP:00053876.6CD4, CD8A, IL10, IL4, LTA, SCYL1
7MP:00036316.6CD4, CD8A, IL10, IL4, LTA, NID1

Publications for Mucocutaneous Leishmaniasis

About this section

Articles related to Mucocutaneous Leishmaniasis:

(show top 50)    (show all 142)
idTitleAuthorsYear
1
Mucocutaneous leishmaniasis. (26994882)
2016
2
Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management. (26568336)
2015
3
Mucocutaneous leishmaniasis of the nose: a case report. (26513953)
2015
4
Cutaneous and mucocutaneous leishmaniasis: Clinical perspectives. (26568335)
2015
5
Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports. (25442251)
2015
6
A case of mucocutaneous leishmaniasis diagnosed by serology. (25041360)
2014
7
Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update. (23637917)
2013
8
Mucocutaneous leishmaniasis: knowledge, attitudes, and practices among paraguayan communities, patients, and health professionals. (23690792)
2013
9
Cutaneous and mucocutaneous leishmaniasis. (22632640)
2012
10
Accurate and rapid species typing from cutaneous and mucocutaneous leishmaniasis lesions of the New World. (22819605)
2012
11
Comment on: Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns. (19836815)
2010
12
Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns. (19356780)
2009
13
Successful diagnosis and treatment 50 years after exposure: is mucocutaneous leishmaniasis still a neglected differential diagnosis? (19090806)
2008
14
Cytokine profile in Montenegro skin test of patients with localized cutaneous and mucocutaneous leishmaniasis. (19082374)
2008
15
Multiple hybrid genotypes of Leishmania (viannia) in a focus of mucocutaneous Leishmaniasis. (17360886)
2007
16
Parenteral aminosidine is not effective for Peruvian mucocutaneous leishmaniasis. (17556623)
2007
17
Resistance to oxidative stress is associated with metastasis in mucocutaneous leishmaniasis. (16991092)
2006
18
Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa. (16574379)
2006
19
A case of mucocutaneous leishmaniasis. (15886638)
2005
20
Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America. (15472268)
2004
21
Itraconazole in the treatment of New World mucocutaneous leishmaniasis. (15357745)
2004
22
Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid. (12956682)
2003
23
A case of mucocutaneous leishmaniasis. (11816390)
2002
24
Chronic dacryocystitis in American mucocutaneous leishmaniasis. (11206745)
2001
25
Tumour necrosis factor alpha and mucocutaneous leishmaniasis. (10234190)
1999
26
Cutaneous and mucocutaneous leishmaniasis. (8620680)
1996
27
Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. (7595196)
1995
28
Rural campaign to diagnose and treat mucocutaneous leishmaniasis in Bolivia. (7614666)
1995
29
Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-gamma and pentavalent antimonial compounds. (8154019)
1994
30
American mucocutaneous leishmaniasis. (7805299)
1994
31
Mucocutaneous leishmaniasis: a clinicopathologic classification. (8496456)
1993
32
American cutaneous and mucocutaneous leishmaniasis (tegumentary): a diagnostic challenge. (1492379)
1992
33
Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. (1842401)
1991
34
Prevalence of mucocutaneous leishmaniasis in littoral Bahia, Brazil. (2389315)
1990
35
Histological analysis and the pathogenesis of mucocutaneous leishmaniasis. (2614573)
1989
36
Evaluation of a skin test on the canine mucocutaneous leishmaniasis diagnosis. (3078346)
1988
37
Frequency of Leishmania-reactive T cells in lesions of American mucocutaneous leishmaniasis (AMCL) patients. Its relevance in the process of healing or aggravation of the disease. (3267032)
1988
38
Mucocutaneous leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity. (4025684)
1985
39
Specific IgE antibodies to Leishmania braziliensis in patients with mucocutaneous leishmaniasis. (6625531)
1983
40
A simple method for the collection of material from cutaneous and mucocutaneous leishmaniasis lesions. (6665854)
1983
41
Further trials of nifurtimox in mucocutaneous leishmaniasis. (7324099)
1981
42
Immunoenzymatic assy (ELISA) in mucocutaneous leishmaniasis, kala-azar, and Chagas' disease: an epimastigote Trypanosoma cruzi antigen able to distinguish between anti-Trypanosoma and anti-Leishmania antibodies. (6792937)
1981
43
The practical importance of culturing Leishmania isolated from patients with cutaneous or mucocutaneous leishmaniasis. (7324141)
1981
44
A histological classification of mucocutaneous leishmaniasis in Brazil and its clinical evaluation. (7445048)
1980
45
Failure of metronidazole treatment in Ethiopian mucocutaneous leishmaniasis. (708614)
1978
46
Mucocutaneous leishmaniasis--an unsolved clinical problem. (841692)
1977
47
Use of amphotericin B in mucocutaneous leishmaniasis. (933229)
1976
48
Leishmaniasis in Brazil: X. Some observations of intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis. (52214)
1975
49
Antigenic standardization for mucocutaneous leishmaniasis immunofluorescence test. (4608167)
1974
50
THE HUMAN TRYPANOSOMATIDAE. IV. CUTANEOUS AND MUCOCUTANEOUS LEISHMANIASIS. (14083450)
1963

Variations for Mucocutaneous Leishmaniasis

About this section

Expression for genes affiliated with Mucocutaneous Leishmaniasis

About this section
Search GEO for disease gene expression data for Mucocutaneous Leishmaniasis.

Pathways for genes affiliated with Mucocutaneous Leishmaniasis

About this section

Pathways related to Mucocutaneous Leishmaniasis according to GeneCards Suite gene sharing:

(show all 22)
idSuper pathwaysScoreTop Affiliating Genes
19.7CD4, CD8A
29.6IL10, TNF
39.6IL10, TNF
4
Show member pathways
9.6IL10, TNF
59.3CD4, IL10, IL4
6
Show member pathways
9.3CD4, CD8A, IL4
7
Show member pathways
9.2CD4, IL10, TNF
8
Show member pathways
9.1IL10, IL4, TNF
98.8CD4, CD8A, IL10, TNF
108.8IL10, IL4, LTA
118.8IL10, IL4, LTA
128.8CD4, IL10, IL4, TNF
138.7CD4, CD8A, IL4, TNF
14
Show member pathways
8.4CD4, IL10, LTA, TNF
158.4CD4, CD8A, IL10, IL4, TNF
16
Show member pathways
8.4CD4, CD8A, IL10, IL4, TNF
17
Show member pathways
8.3IL10, IL4, LTA, TNF
188.3IL10, IL4, LTA, TNF
19
Show member pathways
8.0CD4, IL10, IL4, LTA, TNF
20
Show member pathways
8.0CD4, IL10, IL4, LTA, TNF
217.5CD4, CD8A, IL10, IL4, LTA, TNF
22
Show member pathways
7.5CD4, CD8A, IL10, IL4, LTA, TNF

GO Terms for genes affiliated with Mucocutaneous Leishmaniasis

About this section

Biological processes related to Mucocutaneous Leishmaniasis according to GeneCards Suite gene sharing:

(show all 20)
idNameGO IDScoreTop Affiliating Genes
1defense response to protozoanGO:004283210.2IL10, IL4
2receptor biosynthetic processGO:003280010.2IL10, TNF
3type 2 immune responseGO:004209210.2IL10, IL4
4B cell differentiationGO:003018310.2IL10, IL4
5negative regulation of cytokine secretion involved in immune responseGO:000274010.2IL10, TNF
6positive regulation of mononuclear cell migrationGO:007167710.1IL4, TNF
7positive regulation of chemokine biosynthetic processGO:004508010.1IL4, TNF
8negative regulation of endothelial cell apoptotic processGO:200035210.1IL10, IL4
9negative regulation of growth of symbiont in hostGO:004413010.1IL10, TNF
10negative regulation of nitric oxide biosynthetic processGO:004501910.1IL10, IL4
11negative regulation of interleukin-6 productionGO:003271510.0IL10, TNF
12positive regulation of MHC class II biosynthetic processGO:004534810.0IL10, IL4
13positive regulation of calcium-mediated signalingGO:005085010.0CD4, CD8A
14positive regulation of chronic inflammatory response to antigenic stimulusGO:00028769.7LTA, TNF
15response to organic substanceGO:00100339.6IL10, TNF
16positive regulation of interferon-gamma productionGO:00327299.5LTA, TNF
17positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.5IL10, IL4, TNF
18T cell activationGO:00421109.4CD4, CD8A
19response to drugGO:00424938.9IL10, IL4, LTA
20immune responseGO:00069558.8CD4, IL10, IL4, TNF

Molecular functions related to Mucocutaneous Leishmaniasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1coreceptor activityGO:00150269.7CD4, CD8A

Sources for Mucocutaneous Leishmaniasis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet